MCLEODRUSSBSEMcleod Russel India LtdHighNeutral
Announced Fri, 29 May · 21:52 IST

Outcome of Board Meeting dated 29th May, 2026

Adverse OpinionGoing ConcernExceptional ItemRelated Party TransactionsContingent Liabilities IncreasedPat NegativeResults View source PDF

MCLEODRUSS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹78.41
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.9-5.9-7.7-9.6-11.4-14.9-18.8-24.9
Up moveDown movePending
AI summary

McLeod Russel India Limited reported audited financial results for FY2026 (year ended March 31, 2026) with a net loss of Rs. 9,086 lakhs, down from Rs. 19,636 lakhs loss in FY2025. Total income declined to Rs. 99,672 lakhs from Rs. 1,02,667 lakhs. The company's statutory auditors (Lodha & Co LLP) issued an ADVERSE OPINION, the most serious audit qualification, citing multiple material uncertainties. Key concerns include Inter Corporate Deposits (ICDs) of Rs. 2,86,050 lakhs given to promoter group entities that are doubtful of recovery, with Rs. 2,44,629 lakhs provided against them. The company has negative net worth (Other Equity: Rs. -18,293 lakhs) and current liabilities exceed current assets. Debt restructuring has been approved with NARCL (Rs. 2,48,330 lakhs) and JCAF (Rs. 74,966 lakhs), allowing unsustainable debt portions to be written off. Exceptional items of Rs. 14,695 lakhs include additional ICD provisions and debt restructuring adjustments.

Likely market impact

This is a highly negative development for shareholders. The adverse audit opinion, negative net worth, and significant ICD provisioning indicate severe financial distress. While debt restructuring provides some relief, execution risk remains high given pending conditions precedent and ongoing regulatory investigations.